Heartflow, Inc. (HTFL) Revenue, Earnings & Financial Statements
$47.07NASDAQ: HTFLMarket Cap $4.14B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Heartflow, Inc. most recently reported annual revenue of $176.0M, a net loss of $117.0M. Revenue grew at an average annual rate of 42.2% over the last 2 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Heartflow, Inc.: Revenue rose from $87.0M in 2023 to $176.0M in 2025, a change of +102.3% over 2 years; net profit was positive in 0 of 3 reported years; operating margin moved from -83.6% to -36.4%, a shift of +47.3 percentage points; the most recent year shows a net loss of $117.0M.
Income Statement — 3 Years (USD millions)
Metric
2023
2024
2025
Revenue
$87.0M
$126.0M
$176.0M
Operating Expenses
$160.0M
$187.0M
$240.0M
Operating Profit
−$73.0M
−$61.0M
−$64.0M
Operating Margin
-83.6%
-48.7%
-36.4%
Other Income
−$22.0M
−$35.0M
−$53.0M
Interest
$25.0M
$23.0M
$15.0M
Depreciation
$8.0M
$8.0M
$9.0M
Profit Before Tax
−$95.0M
−$96.0M
−$117.0M
Tax rate (%)
-0.6%
-0.1%
0.1%
Net Profit
−$96.0M
−$96.0M
−$117.0M
EPS
−$1.94
−$1.53
−$1.37
Quarterly Results — Last 11 Quarters (USD millions)
Metric
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$27.0M
$31.0M
$33.0M
$35.0M
$37.0M
$43.0M
$46.0M
$49.0M
$53.0M
$64.0M
$73.0M
Operating Expenses
$43.0M
$45.0M
$48.0M
$51.0M
$55.0M
$57.0M
$61.0M
$67.0M
$75.0M
$82.0M
$87.0M
Operating Profit
−$16.0M
−$14.0M
−$15.0M
−$16.0M
−$18.0M
−$14.0M
−$15.0M
−$18.0M
−$22.0M
−$18.0M
−$14.0M
Operating Margin
-59.8%
-45.6%
-45.3%
-45.9%
-47.0%
-31.6%
-32.6%
-36.1%
-41.9%
-27.9%
-19.0%
Interest
$6.0M
$6.0M
$5.0M
$5.0M
$5.0M
$7.0M
$3.0M
$0
$0
$0
$0
Profit Before Tax
−$21.0M
−$23.0M
−$19.0M
−$33.0M
−$32.0M
−$9.0M
−$51.0M
−$25.0M
−$27.0M
−$16.0M
−$11.0M
Tax rate (%)
0.3%
-0.5%
0.0%
-0.0%
0.0%
-0.7%
-0.1%
0.7%
-0.1%
-0.1%
0.2%
Net Profit
−$21.0M
−$23.0M
−$19.0M
−$33.0M
−$32.0M
−$9.0M
−$51.0M
−$24.0M
−$27.0M
−$16.0M
−$12.0M
EPS
−$0.33
−$0.37
−$0.30
−$0.52
−$0.51
−$0.11
−$0.63
−$0.29
−$0.32
−$0.18
−$0.13
Over the 3 years reported for Heartflow, Inc., borrowings decreased from $161.0M in 2023 to $22.0M in 2025, cash stood at $45.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 5.24 times.
Balance Sheet — 3 Years (USD millions)
Metric
2023
2024
2025
Total Assets
$185.0M
$119.0M
$359.0M
Current Assets
$148.0M
$82.0M
$220.0M
Cash
$123.0M
$51.0M
$45.0M
Inventory
$0
$0
$0
Receivables
$22.0M
$27.0M
$29.0M
Fixed Assets
$23.0M
$20.0M
$26.0M
Capital Work in Progress
$0
$0
$0
Investments
$0
$0
$235.0M
Other Assets
$0
$0
$0
Total Liabilities
$963.0M
$978.0M
$59.0M
Current Liabilities
$33.0M
$34.0M
$42.0M
Borrowings
$161.0M
$160.0M
$22.0M
Other Liabilities
$802.0M
$818.0M
$37.0M
Equity
$0
$0
$0
Reserves
−$778.0M
−$859.0M
$301.0M
For Heartflow, Inc., operating cash flow was positive in 0 of 3 reported years; free cash flow in the latest year was negative at $59.0M; free cash flow was positive in 0 of 3 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 3 Years (USD millions)
Metric
2023
2024
2025
Operating Cash Flow
−$76.0M
−$69.0M
−$54.0M
Investing Cash Flow
−$12.0M
−$9.0M
−$244.0M
Financing Cash Flow
$0
$2.0M
−$1.0M
Net Cash Flow
$86.0M
−$71.0M
−$7.0M
Free Cash Flow
−$83.0M
−$73.0M
−$59.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
-1.04
EV / EBITDA
-69.83
FCF Yield
-1.08%
Quick Ratio
4.41
Interest Coverage
-11919.67
Return 1Y
56.63%
Return 3Y
—
Return 5Y
—
Heartflow, Inc. (HTFL) financials — frequently asked questions
What is Heartflow, Inc.'s annual revenue?
Heartflow, Inc. (HTFL) reported annual revenue of $176.0M in its most recent fiscal year.
What is Heartflow, Inc.'s net profit?
Heartflow, Inc. (HTFL) reported a net loss of $117.0M in its most recent fiscal year.
What is HTFL EV/EBITDA?
Heartflow, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -69.83. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Medical - Healthcare Information Services stocks